Sarah L. Sammons
Oncology
450 Brookline Avenue
Susan F. Smith Center For Women's Cancers
Boston, MA 02115
Susan F. Smith Center For Women's Cancers
Boston, MA 02115
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Systemic Therapy Considerations in Older Adults With Early-Stage Breast Cancer: A Review.
Journal: JAMA oncology
Published: August 27, 2026
The role of radiation therapy in leptomeningeal disease from breast cancer - a multicenter analysis.
The role of radiation therapy in leptomeningeal disease from breast cancer - a multicenter analysis.
Journal: Clinical and translational radiation oncology
Published: May 05, 2026
TRADE: tolerability of adjuvant abemaciclib at 6 months after initial dose escalation in patients with early-stage HR-positive/HER2-negative breast cancer.
Journal: ESMO open
Published: April 10, 2026
Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 18, 2026
Real-world postprogression outcomes after first-line treatment with ribociclib plus aromatase inhibitor versus aromatase inhibitor alone in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in the United States of America.
Journal: ESMO open
Published: February 02, 2026
Intracranial progression-free survival correlates with overall survival and varies by tumor subtype in patients with breast cancer and brain metastases.
Journal: Neuro-oncology
Published: January 09, 2026
Comparative cost-effectiveness of ribociclib and palbociclib as first-line treatment for HR+/HER2- advanced breast cancer in postmenopausal women: analysis from a Medicare perspective.
Journal: Journal of medical economics
Published: December 08, 2025
Cost-effectiveness analysis of ribociclib versus abemaciclib as first-line treatments for postmenopausal women with HR+/HER2- advanced breast cancer: a Medicare perspective.
Journal: Journal of medical economics
Published: December 05, 2025
Scalp cooling outcomes in patients receiving trastuzumab deruxtecan for metastatic breast cancer.
Journal: ESMO open
Published: November 23, 2025
Brain imaging screening in metastatic breast cancer: Is it time to rethink clinical guidelines and practice?
Journal: Breast (Edinburgh, Scotland)
Published: October 13, 2025
Last Updated: 09/26/2026